agilon health, inc. (NYSE:AGL) focuses on empowering physicians to transform healthcare in communities. Operating in the healthcare sector, AGL aims to improve the quality and efficiency of healthcare delivery. The company is scheduled to release its quarterly earnings on Tuesday, August 5, 2025, with Wall Street estimating an earnings per share (EPS) loss of $0.11 and projected revenue of approximately $1.47 billion.
AGL recently announced its financial results for the second quarter ending June 30, 2025. Amidst this, Steven Sell resigned from his roles as President, CEO, and Director of the Board. Ronald A. Williams, co-founder and Board Chairman, has been appointed as Executive Chairman while the Board searches for a permanent replacement. This leadership transition occurs as the company prepares to discuss its financial outcomes in a conference call scheduled for August 5, 2025, at 4:30 PM Eastern Time.
AGL's financial metrics reveal some challenges. The company has a price-to-earnings (P/E) ratio of -3.10, indicating negative earnings relative to its share price, suggesting that the company is currently not profitable. Additionally, the price-to-sales ratio is 0.13, meaning investors are paying 13 cents for every dollar of sales. This low ratio could indicate undervaluation or potential issues in generating revenue.
The enterprise value to sales ratio of 0.11 reflects AGL's valuation in relation to its revenue, while the enterprise value to operating cash flow ratio of -15.63 highlights difficulties in generating cash flow from operations. The earnings yield is -32.29%, indicating a negative return on investment based on current earnings. Despite these challenges, AGL maintains a debt-to-equity ratio of 0.08, suggesting a relatively low level of debt compared to its equity, which can be seen as a positive aspect of its financial health.
AGL's current ratio of 1.20 indicates that the company has a reasonable level of liquidity to cover its short-term liabilities. This means that AGL is in a position to meet its immediate financial obligations, which is crucial for maintaining operations and investor confidence. As the company navigates its leadership transition and prepares for its earnings release, these financial metrics will be closely watched by investors and analysts.
